Veterinary Immunodiagnostics Market- Global Opportunity Analysis And Industry Forecasts To 2022
Global Veterinary Immunodiagnostics Market is expected to reach USD 2,011.3 million by 2022, supported by a CAGR of 9.6% during the forecast period of 2017 to 2022. Veterinary immunodiagnostics has been playing a very important role in the enhancement of animal health. Thus, rising demand for animal derived food products, growth in companion and livestock animals, and growing animal health care expenditure are majorly driving the growth of this market. In addition, growing animal healthcare awareness, rising adoption of animals in developing nations, and increasing government policies on the use of diagnostic products for the betterment of animal health are further expected to boost the growth of the global veterinary immunodiagnostics market.
The global veterinary immunodiagnostics market is segmented by product, animal type, application, technology, end user, and geography. The product market is further classified into two segments, namely analysers and consumables. The consumables segment dominated the overall market in 2016 and is also estimated to continue its dominance over the forecast period owing to their increasing demand to diagnosis of animals for the prevention of transfer of zoonotic disease in human population and to ensure the good quality of animal derived products.
Based on animal type, the veterinary immunodiagnostics market is mainly segmented into livestock and companion animals. The livestock animals segment holds the largest share in 2016, owing to the higher investment in the healthcare of livestock animals with rising demand for animal derived products across the globe.
Veterinary immunodiagnostics Market, By Application, 2017- 2022
veterinary immunodiagnostics market
Source: Meticulous Research Analysis
Geographically, the global Veterinary immunodiagnostics market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global veterinary immunodiagnostics market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher rate of companion animals, higher spending of pet care, well established healthcare system, and large number of veterinarians. On the other hand, Asia-Pacific region is projected to grow at a faster CAGR of 11.4% during the forecast period, due to rising investment in improving animal healthcare infrastructure, growing animal healthcare expenditure, increasing pet care cost, and increasing pet ownership.
The key players in the global Veterinary immunodiagnostics market are Abaxisinc., bioM?rieux SA, IDEXX Laboratories inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., and QIAGEN N.V.
Scope of the Report:
Market by Product type:
The global veterinary immunodiagnostics market is segmented by product, animal type, application, technology, end user, and geography. The product market is further classified into two segments, namely analysers and consumables. The consumables segment dominated the overall market in 2016 and is also estimated to continue its dominance over the forecast period owing to their increasing demand to diagnosis of animals for the prevention of transfer of zoonotic disease in human population and to ensure the good quality of animal derived products.
Based on animal type, the veterinary immunodiagnostics market is mainly segmented into livestock and companion animals. The livestock animals segment holds the largest share in 2016, owing to the higher investment in the healthcare of livestock animals with rising demand for animal derived products across the globe.
Veterinary immunodiagnostics Market, By Application, 2017- 2022
veterinary immunodiagnostics market
Source: Meticulous Research Analysis
Geographically, the global Veterinary immunodiagnostics market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global veterinary immunodiagnostics market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher rate of companion animals, higher spending of pet care, well established healthcare system, and large number of veterinarians. On the other hand, Asia-Pacific region is projected to grow at a faster CAGR of 11.4% during the forecast period, due to rising investment in improving animal healthcare infrastructure, growing animal healthcare expenditure, increasing pet care cost, and increasing pet ownership.
The key players in the global Veterinary immunodiagnostics market are Abaxisinc., bioM?rieux SA, IDEXX Laboratories inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., and QIAGEN N.V.
Scope of the Report:
Market by Product type:
- Analyzers
- Consumables
- Livestock
- Cattle
- Pigs
- Poultry
- Others
- Companion
- Feline
- Canine
- Equine
- Others
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay
- Fluorescent Immunoassay
- Colorimetric Immunoassay
- Radioimmunoassay
- Rapid Test
- Others
- Infectious Disease
- Autoimmune Disorder
- Endocrinology& Oncology
- Bone and Mineral diseases
- Others
- Reference Laboratories
- Academic and Research Institutes
- Veterinary Hospitals & Clinics
- Point of care/ In-house testing
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
- Which are the high growth market segments in terms of product, animal type, application, technology, end user, and regions/countries?
- What is the historical market for veterinary immunodiagnostics market across the globe?
- What are the market forecasts and estimates from the period 2015-2022?
- What are the major drivers, restrains, and trends in the global veterinary immunodiagnostics market?
- Who are the major players in the global veterinary immunodiagnostics market and what share of the market do they hold?
- Who are the major players in various countries and what share of the market do they hold?
- What are the competitive landscapes and who are the market leaders by sub-region in the global veterinary immunodiagnostics market?
- What are the recent developments in the global veterinary immunodiagnostics market?
- What are the different strategies adopted by the major players in the global veterinary immunodiagnostics market?
- What are the geographical trends and high growth regions/ countries?
- Who are the local emerging players in the global veterinary immunodiagnostics market and how do they compete with the global players?
1. INTRODUCTION
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Introduction
4.2. Drivers
4.2.1. Rising Demand for Animal Derived Food Products and Growth in Companion and Livestock Animal Population
4.2.2. Growing Animal Health Expenditure and Rising Pet Health insurance
4.2.3. Increasing Level of Zoonotic and Foodborne Diseases and Growing Prevalence of Animal Diseases
4.2.4. Increasing Number of Veterinary Practitioners in Developed Economics
4.2.5. Increasing Pet Ownerships
4.3. Restraints
4.3.1. Low Animal Health Awareness in Developing Countries
4.3.2. Increasing Pet Care Cost
4.3.3. Cultural Differences to Affect the Adoption of Pet Animals
5. VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE
5.1. Introduction
5.2. Analyzers
5.3. Consumables
6. VETERINARY IMMUNODIAGNOSTICS MARKET, BY ANIMAL TYPE
6.1. Introduction
6.2. Livestock Animals
6.2.1. Cattle
6.2.2. Pigs
6.2.3. Poultry
6.2.4. Other
6.3. Companion Animals
6.3.1. Feline
6.3.2. Canine
6.3.3. Equine
6.3.4. Others
7. VETERINARY IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY
7.1. Introduction
7.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.1. Chemiluminescence Immunoassay
7.2.2. Fluorescent Immunoassay
7.2.3. Colorimetric Immunoassay
7.3. Radioimmunoassay
7.4. Rapid Test
7.5. Other
8. VETERINARY IMMUNODIAGNOSTICS MARKET, BY APPLICATION
8.1. Introduction
8.2. infectious Disease
8.3. Autoimmune Disorder
8.4. Endocrinology & Oncology
8.5. Bone and Mineral Diseases
8.6. Others
9. VETERINARY IMMUNODIAGNOSTICS MARKET, BY END-USER
9.1. Introduction
9.2. Reference Laboratories
9.3. Veterinary Hospitals & Clinics
9.4. Academic and Research institutes
9.5. Point of Care/in-House Testing
10. VETERINARY IMMUNODIAGNOSTICS MARKET, BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. Rest of Asia-Pacific
10.5. Rest of World (Row)
10.5.1. Latin America
10.5.2. Middle East & Africa
11. COMPETITIVE LANDSCAPE
11.1. Introduction
11.2. New Product Launches
11.3. Merges and Acquisitions
11.4. Agreements & Partnerships
11.5. Others
12. COMPANY PROFILES
12.1. Abaxis Inc.
12.1.1. Overview
12.1.2. Financials
12.1.3. Product Portfolio
12.1.4. Recent Developments
12.2. Biomerieux S.A.
12.2.1. Overview
12.2.2. Financials
12.2.3. Product Portfolio
12.2.4. Recent Development
12.3. Idexx Laboratories, Inc.
12.3.1. Overview
12.3.2. Financials
12.3.3. Product Portfolio
12.3.4. Recent Developments
12.4. Heska Corporation
12.4.1. Overview
12.4.2. Financials
12.4.3. Product Portfolio
12.4.4. Recent Development
12.5. Virbac Sa
12.5.1. Overview
12.5.2. Financials
12.5.3. Product Portfolio
12.6. Zoetis Inc.
12.6.1. Overview
12.6.2. Financials
12.6.3. Product Portfolio
12.6.4. Recent Developments
12.7. Id.Vet
12.7.1. Overview
12.7.2. Financials
12.7.3. Product Portfolio
12.8. Randox
12.8.1. Overview
12.8.2. Financials
12.8.3. Product Portfolio
12.9. Neogen Corporation
12.9.1. Overview
12.9.2. Financials
12.9.3. Product Portfolio
12.9.4. Recent Development
12.10. Woodley Veterinary Diagnostics
12.10.1. Overview
12.10.2. Financials
12.10.3. Product Portfolio
12.10.4. Recent Development
12.11. Thermo Fisher Scientific Inc.
12.11.1. Overview
12.11.2. Financials
12.11.3. Product Portfolio
12.12. Qiagen N.V.
12.12.1. Overview
12.12.2. Financials
12.12.3. Product Portfolio
12.12.4. Recent Development
13. APPENDIX
13.1. Questionnaire
13.2. Available customizations
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Introduction
4.2. Drivers
4.2.1. Rising Demand for Animal Derived Food Products and Growth in Companion and Livestock Animal Population
4.2.2. Growing Animal Health Expenditure and Rising Pet Health insurance
4.2.3. Increasing Level of Zoonotic and Foodborne Diseases and Growing Prevalence of Animal Diseases
4.2.4. Increasing Number of Veterinary Practitioners in Developed Economics
4.2.5. Increasing Pet Ownerships
4.3. Restraints
4.3.1. Low Animal Health Awareness in Developing Countries
4.3.2. Increasing Pet Care Cost
4.3.3. Cultural Differences to Affect the Adoption of Pet Animals
5. VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE
5.1. Introduction
5.2. Analyzers
5.3. Consumables
6. VETERINARY IMMUNODIAGNOSTICS MARKET, BY ANIMAL TYPE
6.1. Introduction
6.2. Livestock Animals
6.2.1. Cattle
6.2.2. Pigs
6.2.3. Poultry
6.2.4. Other
6.3. Companion Animals
6.3.1. Feline
6.3.2. Canine
6.3.3. Equine
6.3.4. Others
7. VETERINARY IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY
7.1. Introduction
7.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.1. Chemiluminescence Immunoassay
7.2.2. Fluorescent Immunoassay
7.2.3. Colorimetric Immunoassay
7.3. Radioimmunoassay
7.4. Rapid Test
7.5. Other
8. VETERINARY IMMUNODIAGNOSTICS MARKET, BY APPLICATION
8.1. Introduction
8.2. infectious Disease
8.3. Autoimmune Disorder
8.4. Endocrinology & Oncology
8.5. Bone and Mineral Diseases
8.6. Others
9. VETERINARY IMMUNODIAGNOSTICS MARKET, BY END-USER
9.1. Introduction
9.2. Reference Laboratories
9.3. Veterinary Hospitals & Clinics
9.4. Academic and Research institutes
9.5. Point of Care/in-House Testing
10. VETERINARY IMMUNODIAGNOSTICS MARKET, BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. Rest of Asia-Pacific
10.5. Rest of World (Row)
10.5.1. Latin America
10.5.2. Middle East & Africa
11. COMPETITIVE LANDSCAPE
11.1. Introduction
11.2. New Product Launches
11.3. Merges and Acquisitions
11.4. Agreements & Partnerships
11.5. Others
12. COMPANY PROFILES
12.1. Abaxis Inc.
12.1.1. Overview
12.1.2. Financials
12.1.3. Product Portfolio
12.1.4. Recent Developments
12.2. Biomerieux S.A.
12.2.1. Overview
12.2.2. Financials
12.2.3. Product Portfolio
12.2.4. Recent Development
12.3. Idexx Laboratories, Inc.
12.3.1. Overview
12.3.2. Financials
12.3.3. Product Portfolio
12.3.4. Recent Developments
12.4. Heska Corporation
12.4.1. Overview
12.4.2. Financials
12.4.3. Product Portfolio
12.4.4. Recent Development
12.5. Virbac Sa
12.5.1. Overview
12.5.2. Financials
12.5.3. Product Portfolio
12.6. Zoetis Inc.
12.6.1. Overview
12.6.2. Financials
12.6.3. Product Portfolio
12.6.4. Recent Developments
12.7. Id.Vet
12.7.1. Overview
12.7.2. Financials
12.7.3. Product Portfolio
12.8. Randox
12.8.1. Overview
12.8.2. Financials
12.8.3. Product Portfolio
12.9. Neogen Corporation
12.9.1. Overview
12.9.2. Financials
12.9.3. Product Portfolio
12.9.4. Recent Development
12.10. Woodley Veterinary Diagnostics
12.10.1. Overview
12.10.2. Financials
12.10.3. Product Portfolio
12.10.4. Recent Development
12.11. Thermo Fisher Scientific Inc.
12.11.1. Overview
12.11.2. Financials
12.11.3. Product Portfolio
12.12. Qiagen N.V.
12.12.1. Overview
12.12.2. Financials
12.12.3. Product Portfolio
12.12.4. Recent Development
13. APPENDIX
13.1. Questionnaire
13.2. Available customizations
